ramelteon and levodopa
ramelteon has been researched along with levodopa in 2 studies
Compound Research Comparison
Studies (ramelteon) | Trials (ramelteon) | Recent Studies (post-2010) (ramelteon) | Studies (levodopa) | Trials (levodopa) | Recent Studies (post-2010) (levodopa) |
---|---|---|---|---|---|
317 | 59 | 204 | 17,774 | 1,900 | 4,946 |
Protein Interaction Comparison
Protein | Taxonomy | ramelteon (IC50) | levodopa (IC50) |
---|---|---|---|
integrase, partial | Human immunodeficiency virus 1 | 0.5939 | |
lens epithelium-derived growth factor p75 | Homo sapiens (human) | 0.5939 | |
Epidermal growth factor receptor | Homo sapiens (human) | 2.88 | |
Tyrosine-protein kinase Lck | Homo sapiens (human) | 3.729 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.146 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.258 |
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Kashihara, K; Maeda, T; Mishima, T; Nakashima, K; Nomura, T; Takigawa, H; Tsuboi, Y | 1 |
Trials
1 trial(s) available for ramelteon and levodopa
Article | Year |
---|---|
Beneficial Effects of Ramelteon on Rapid Eye Movement Sleep Behavior Disorder Associated with Parkinson's Disease - Results of a Multicenter Open Trial.
Topics: Aged; Antiparkinson Agents; Female; Humans; Hypnotics and Sedatives; Indenes; Japan; Levodopa; Male; Middle Aged; Parkinson Disease; REM Sleep Behavior Disorder; Surveys and Questionnaires; Treatment Outcome | 2016 |
Other Studies
1 other study(ies) available for ramelteon and levodopa
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |